{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:18:29Z","timestamp":1773677909224,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clgc.2026.102510","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:04:50Z","timestamp":1769011490000},"page":"102510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-Reported Outcomes and Long-Term Toxicity in stage I TGCT: A Retrospective Single-Center Cohort (1994-2023)"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6803-8228","authenticated-orcid":false,"given":"Patricia","family":"Capdevila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-0786","authenticated-orcid":false,"given":"Jorge","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clgc.2026.102510_bib0001","first-page":"3275","article-title":"Testicular cancer as a model for a curable neoplasm: the Richard and Hinda Rosenthal Foundation Award Lecture","volume":"41","author":"Einhorn","year":"1981","journal-title":"Cancer Res"},{"issue":"28","key":"10.1016\/j.clgc.2026.102510_bib0002","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.2014.56.0896","article-title":"Testicular cancer: a reflection on 50 years of discovery","volume":"32","author":"Hanna","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102510_bib0003","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","article-title":"Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oldenburg","year":"2022","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.clgc.2026.102510_bib0004","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12094-016-1566-1","article-title":"SEOM clinical guidelines for the management of germ cell testicular cancer (2016)","volume":"18","author":"Aparicio","year":"2016","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102510_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.eururo.2023.04.010","article-title":"European Association of Urology Guidelines on Testicular Cancer: 2023 update","volume":"84","author":"Patrikidou","year":"2023","journal-title":"Eur Urol"},{"issue":"35","key":"10.1016\/j.clgc.2026.102510_bib0006","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1200\/JCO.2011.36.0503","article-title":"Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study","volume":"29","author":"Aparicio","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102510_bib0007","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.euo.2023.10.014","article-title":"Prognostic factor risk groups for clinical stage I seminoma: an individual patient Data analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office","volume":"7","author":"Boormans","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102510_bib0008","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","article-title":"Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance","volume":"33","author":"Kollmannsberger","year":"2015","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.clgc.2026.102510_bib0009","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102510_bib0010","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/annonc\/mdu375","article-title":"One course of adjuvant BEP in clinical stage I nonseminoma: mature and expanded results from the SWENOTECA group","volume":"25","author":"Tandstad","year":"2014","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.clgc.2026.102510_bib0011","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1200\/JCO.2009.26.4655","article-title":"Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19\/EORTC 30982 study (ISRCTN27163214)","volume":"29","author":"Oliver","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102510_bib0012","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.eururo.2019.11.022","article-title":"The 111 study: A single-arm, phase 3 trial evaluating one cycle of bleomycin, etoposide, and cisplatin as adjuvant chemotherapy in high-risk, stage 1 nonseminomatous or combined germ cell tumours of the testis","volume":"77","author":"Cullen","year":"2020","journal-title":"Eur Urol"},{"issue":"15","key":"10.1016\/j.clgc.2026.102510_bib0013","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/jnci\/djq216","article-title":"Testicular cancer survivorship: research strategies and recommendations","volume":"102","author":"Travis","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"30","key":"10.1016\/j.clgc.2026.102510_bib0014","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","article-title":"Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up","volume":"30","author":"Haugnes","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2026.102510_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/PROM.S242754","article-title":"Patient-reported outcomes associated with treatments for testicular cancer: a systematic review","volume":"12","author":"Mercieca-Bebber","year":"2021","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.clgc.2026.102510_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fruro.2023.1174626","article-title":"Understanding the health-related quality of life and treatment-related side-effects in patients who have been in remission from testicular cancer for 12\u201324 months","volume":"3","author":"Cazzaniga","year":"2023","journal-title":"Front Urol"},{"issue":"35","key":"10.1016\/j.clgc.2026.102510_bib0017","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1200\/JCO.2008.19.6931","article-title":"Health-related quality of life in long-term survivors of testicular cancer","volume":"27","author":"Rossen","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102510_bib0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11764-019-00835-0","article-title":"Psychological stress in long-term testicular cancer survivors: a Danish nationwide cohort study","volume":"14","author":"Kreiberg","year":"2020","journal-title":"J Cancer Surviv"},{"issue":"5","key":"10.1016\/j.clgc.2026.102510_bib0019","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/annonc\/mdu514","article-title":"Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer","volume":"26","author":"Oldenburg","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2026.102510_bib0020","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-025-04068-9","article-title":"Epidemiological patterns, temporal trends in management and long-term outcomes in testicular cancer: a 30-year single center experience","author":"Capdevila","year":"2025","journal-title":"Clin Transl Oncol"},{"issue":"19","key":"10.1016\/j.clgc.2026.102510_bib0021","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1200\/JCO.22.01016","article-title":"Cardiovascular disease in testicular cancer survivors: identification of risk factors and impact on quality of life","volume":"41","author":"Lubberts","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2026.102510_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1654063","article-title":"Cardiovascular toxicity in testicular germ cell tumor survivors","volume":"15","author":"Orszaghova","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.clgc.2026.102510_bib0023","article-title":"Increased cardiovascular risk in testicular cancer survivors\u2014analysis based on metabolic study findings in a single-center cohort","author":"Begier","year":"2025","journal-title":"Oncol Clin Pract"},{"issue":"11","key":"10.1016\/j.clgc.2026.102510_bib0024","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s12094-017-1742-y","article-title":"Long-term cardiovascular complications in stage I seminoma patients","volume":"19","author":"Terbuch","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clgc.2026.102510_bib0025","series-title":"Nota T\u00e9cnica \/Resultados Detallados (presentaci\u00f3n de resultados)","year":"2023"},{"issue":"12","key":"10.1016\/j.clgc.2026.102510_bib0026","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.annonc.2023.09.3101","article-title":"Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective","volume":"34","author":"Foss\u00e5","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2026.102510_bib0027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.urology.2021.02.039","article-title":"Health-related quality of life in testicular cancer survivors in Japan: a multi-institutional, cross-sectional study using the EORTC QLQ-TC26","volume":"156","author":"Yamashita","year":"2021","journal-title":"Urology."},{"issue":"1","key":"10.1016\/j.clgc.2026.102510_bib0028","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1186\/s12885-018-5036-8","article-title":"International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26","volume":"18","author":"Sztankay","year":"2018","journal-title":"BMC Cancer."},{"issue":"5","key":"10.1016\/j.clgc.2026.102510_bib0029","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s11764-024-01580-9","article-title":"Long-term quality of life of testicular cancer survivors differs according to applied adjuvant treatment and tumour type","volume":"19","author":"Heinzelbecker","year":"2025","journal-title":"J Cancer Surviv"},{"issue":"4","key":"10.1016\/j.clgc.2026.102510_bib0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11764-020-00944-1","article-title":"Long-term neurotoxicity and quality of life in testicular cancer survivors-a nationwide cohort study","volume":"15","author":"Lauritsen","year":"2021","journal-title":"J Cancer Surviv"},{"issue":"7","key":"10.1016\/j.clgc.2026.102510_bib0031","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jamaoncol.2024.1233","article-title":"Comprehensive audiologic analyses after cisplatin-based chemotherapy","volume":"10","author":"Sanchez","year":"2024","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102510_bib0032","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.juro.2018.04.077","article-title":"Sexual function in a nationwide cohort of 2,260 survivors of testicular cancer after 17 years of followup","volume":"200","author":"Bandak","year":"2018","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102510_bib0033","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.euf.2018.11.007","article-title":"Sexual function and quality of life in a national cohort of survivors of bilateral testicular cancer","volume":"6","author":"Bandak","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"8","key":"10.1016\/j.clgc.2026.102510_bib0034","first-page":"529","article-title":"The experience of fertility concerns in patients with testicular cancer: a qualitative study","volume":"32","author":"Hu","year":"2024","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.clgc.2026.102510_bib0035","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO-24-02782","article-title":"Fertility preservation in people with cancer: ASCO guideline update","volume":"43","author":"Su","year":"2025","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102510_bib0036","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3390\/cancers17111826","article-title":"Impact of testicular cancer on the socio-economic health, sexual health, and fertility of survivors-A questionnaire based survey","volume":"17","author":"Khan","year":"2025","journal-title":"Cancers (Basel)"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:53:08Z","timestamp":1773672788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1558767326000108"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102510","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Reported Outcomes and Long-Term Toxicity in stage I TGCT: A Retrospective Single-Center Cohort (1994-2023)","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102510"}}